Skip to main content

Table 1 Characteristics of elderly patients with hepatocellular carcinoma

From: Effect of timing of surgical resection of primary hepatocellular carcinoma on survival outcomes in elderly patients and prediction of clinical models

Variables

Overall (N = 232)

Age*

62 (64–67.8)

Sex

 

Male

174 (75%)

Female

58 (25%)

BMI*

22.7 (20.6–24.8)

Smoking

 

Yes

69 (27.9%)

No

163 (70.3%)

Alcohol

 

Yes

66 (28.4%)

No

166 (71.6%)

Diabetes

 

Yes

34 (14.7%)

No

198 (85.3%)

BCLC stage

 

0–A stage

190 (81.9%)

B–C stage

42 (18.1%)

Child-Pugh

 

Grade A

222 (95.7%)

Grade B

10 (4.3%)

Liver cirrhosis

 

Yes

108 (46.6%)

No

124 (53.4%)

Liver fluke

 

Yes

22 (9.5%)

No

210 (90.5%)

Viral hepatitis B

 

Yes

161 (69.4%)

No

71 (30.6%)

Viral hepatitis C

 

Yes

9 (3.9%)

No

223 (96.1%)

AFP, ng/mL

 

≤ 8

65 (28%)

>8

167 (72%)

Tumor number

 

Single

202 (87.1%)

Multiple

30 (12.9%)

Tumor size, cm

 

<5

132 (56.9%)

≥ 5

100 (43.1%)

Venous tumor emboli

 

Yes

28 (12.1%)

No

204 (87.9%)

Time of operation*

240 (172–296)

Bleeding*

350 (200–600)

Local chemotherapy

 

Yes

73 (31.5%)

No

159 (68.5%)

Radical resection

 

Yes

139 (59.5%)

No

94 (40.5%)

Laparoscopic hepatectomy

 

Yes

54 (23.3%)

No

178 (76.7%)

Differentiated degree

 

High

14 (6%)

Middle

205 (88.4%)

Low

13 (5.6%)

Microvascular invasion

 

Yes

64 (27.6%)

No

168 (72.4%)

Length of stay*

18 (14–22)

Clavien–Dindo

 

I and II

226 (97.4%)

III, IV and V

6 (2.6%)

Overall survival*

37 (23.4–57.6)

Survival status

 

Alive

184 (79.3%)

Death

48 (20.7%)

Recurrence

 

Yes

69 (29.7%)

No

163 (70.3%)

TTS*

18 (14–29.8)

  1. *Median (IQR).AFP indicates alpha-fetoprotein;BMI, body-mass index;IQR, interquartile range